Tower Research Capital LLC (Trc) Beam Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.29 Billion
  • Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 14,953 shares of BEAM stock, worth $265,415. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,953
Previous 1,372 989.87%
Holding current value
$265,415
Previous $34,000 758.82%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$19.53 - $34.09 $265,236 - $462,976
13,581 Added 989.87%
14,953 $292,000
Q4 2024

Feb 13, 2025
SELL
$21.55 - $30.35 $111,456 - $156,970
-5,172 Reduced 79.03%
1,372 $34,000
Q3 2024

Nov 14, 2024
SELL
$22.57 - $33.14 $492,454 - $723,081
-21,819 Reduced 76.93%
6,544 $160,000
Q2 2024

Aug 13, 2024
BUY
$21.22 - $32.66 $473,609 - $728,938
22,319 Added 369.28%
28,363 $664,000
Q1 2024

May 15, 2024
SELL
$23.46 - $45.07 $5,114 - $9,825
-218 Reduced 3.48%
6,044 $199,000
Q4 2023

Feb 13, 2024
BUY
$17.69 - $30.76 $38,351 - $66,687
2,168 Added 52.96%
6,262 $170,000
Q3 2023

Nov 14, 2023
SELL
$23.01 - $32.46 $168,548 - $237,769
-7,325 Reduced 64.15%
4,094 $98,000
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $168,853 - $207,266
5,759 Added 101.75%
11,419 $364,000
Q1 2023

May 09, 2023
BUY
$30.15 - $48.79 $123,313 - $199,551
4,090 Added 260.51%
5,660 $173,000
Q4 2022

Feb 10, 2023
SELL
$36.73 - $51.6 $1.21 Million - $1.7 Million
-32,893 Reduced 95.44%
1,570 $61,000
Q3 2022

Nov 10, 2022
BUY
$39.79 - $70.31 $409,080 - $722,857
10,281 Added 42.52%
34,463 $1.64 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $42,789 - $89,361
1,433 Added 6.3%
24,182 $936,000
Q1 2022

May 12, 2022
BUY
$53.73 - $82.16 $1.08 Million - $1.65 Million
20,059 Added 745.69%
22,749 $1.3 Million
Q4 2021

Feb 14, 2022
SELL
$68.02 - $99.06 $110,600 - $161,071
-1,626 Reduced 37.67%
2,690 $215,000
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $178,948 - $283,365
2,121 Added 96.63%
4,316 $376,000
Q2 2021

Aug 16, 2021
SELL
$64.12 - $128.71 $1.24 Million - $2.49 Million
-19,370 Reduced 89.82%
2,195 $283,000
Q1 2021

May 17, 2021
BUY
$71.28 - $120.75 $1.29 Million - $2.18 Million
18,075 Added 517.91%
21,565 $1.73 Million
Q4 2020

Feb 16, 2021
SELL
$22.24 - $95.63 $319,121 - $1.37 Million
-14,349 Reduced 80.44%
3,490 $285,000
Q3 2020

Nov 16, 2020
BUY
$19.0 - $30.57 $289,275 - $465,428
15,225 Added 582.44%
17,839 $439,000
Q2 2020

Aug 13, 2020
BUY
$15.26 - $28.66 $39,889 - $74,917
2,614 New
2,614 $73,000

Others Institutions Holding BEAM

# of Institutions
258
Shares Held
93.6M
Call Options Held
425K
Put Options Held
309K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.25B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email